Glaucoma News

KIAWAH ISLAND, S.C. — At the Kiawah Eye meeting here, John Berdahl, MD, shares surgical pearls for transitioning from implanting the iStent to implanting the iStent inject (both Glaukos).

KIAWAH ISLAND, S.C. — At the Kiawah Eye meeting here, Nathan Radcliffe, MD, discusses how and why switching from an ab interno to ab externo technique with implantation of the Xen gel stent MIGS device (Allergan) has improved his results in treating patients with glaucoma.

KIAWAH ISLAND, S.C. — At the Kiawah Eye meeting here, Keith Walter, MD, discusses his personal experience adopting iStent inject (Glaukos) in a hospital setting and his own technique, which has left many of his patients with a 50% reduction in IOP.

KIAWAH ISLAND, S.C. — At the Kiawah Eye meeting here, Thomas W. Samuelson, MD, discusses the strengths and weaknesses of the new MIGS devices on the U.S. market, including the iStent inject (Glaukos), Hydrus (Ivantis), Xen (Allergan) and Omni (Sight Sciences) devices.

Researchers found that glaucoma patients older than 65 years were four times more likely to have cognitive impairment than younger patients.

Researchers found a strong correlation between vertical cup-to-disc ratios obtained with an electronic mobile device and spectral domain OCT.

Researchers found the use of primary selective laser trabeculoplasty in treatment-naïve eyes with open angle glaucoma or ocular hypertension to be safe and effective.

Rates of visual field progression were found to be faster in patients with high tension glaucoma than in those with primary angle closure glaucoma, at similar baseline severity.

SAN DIEGO — At the American Society of Cataract and Refractive Surgery meeting, E. Randy Craven, MD, discusses a study looking at the long-term IOP-lowering effects of Bimatoprost SR (Allergan) in patients with glaucoma.

SAN DIEGO — At the American Society of Cataract and Refractive Surgery meeting, Jason Bacharach, MD, discusses how he incorporates use of the Kahook Dual Blade (New World Medical) in his MIGS strategy for the treatment of glaucoma.